THOMPSON SIEGEL & WALMSLEY LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
6641 WEST BROAD STREET RICHMOND, VA 23230
As of the latest 13F report, the guru’s equity portfolio contained 560 stocks valued at a total of $6.19Bil. The top holdings were AER(2.12%), LIN(1.87%), and POST(1.82%).
According to GuruFocus data, these were THOMPSON SIEGEL & WALMSLEY LLC’s top five trades of the quarter.
Alleghany Corp
The guru sold out of their 149,266-share investment in NYSE:Y. Previously, the stock had a 2.17% weight in the equity portfolio. Shares traded for an average price of $843.86 during the quarter.
On 02/12/2023, Alleghany Corp traded for a price of $847.79 per share and a market cap of $11.41Bil. The stock has returned 27.62% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Alleghany Corp has a price-earnings ratio of 33.43, a price-book ratio of 1.44, a price-earnings-to-growth (PEG) ratio of 1.49, a EV-to-Ebitda ratio of 13.62 and a price-sales ratio of 0.99.
The price-to-GF Value ratio is 0.96, earning the stock a GF Value rank of 5.
Bio-Rad Laboratories Inc
During the quarter, THOMPSON SIEGEL & WALMSLEY LLC bought 182,248 shares of NYSE:BIO for a total holding of 201,222. The trade had a 1.24% impact on the equity portfolio. During the quarter, the stock traded for an average price of $403.63.
On 02/12/2023, Bio-Rad Laboratories Inc traded for a price of $471.18 per share and a market cap of $13.71Bil. The stock has returned -24.63% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Bio-Rad Laboratories Inc has a price-book ratio of 1.66, a EV-to-Ebitda ratio of -1.72 and a price-sales ratio of 5.03.
The price-to-GF Value ratio is 0.78, earning the stock a GF Value rank of 9.
Exelon Corp
The guru established a new position worth 969,267 shares in NAS:EXC, giving the stock a 0.68% weight in the equity portfolio. Shares traded for an average price of $39.51 during the quarter.
On 02/12/2023, Exelon Corp traded for a price of $40.71 per share and a market cap of $40.46Bil. The stock has returned 0.05% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Exelon Corp has a price-earnings ratio of 18.85, a price-book ratio of 1.65, a price-earnings-to-growth (PEG) ratio of 8.28, a EV-to-Ebitda ratio of 7.20 and a price-sales ratio of 1.07.
The price-to-GF Value ratio is 2.22, earning the stock a GF Value rank of 1.
Arch Capital Group Ltd
THOMPSON SIEGEL & WALMSLEY LLC reduced their investment in NAS:ACGL by 699,850 shares. The trade had a 0.55% impact on the equity portfolio. During the quarter, the stock traded for an average price of $55.83.
On 02/12/2023, Arch Capital Group Ltd traded for a price of $64.22 per share and a market cap of $23.75Bil. The stock has returned 35.51% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Arch Capital Group Ltd has a price-earnings ratio of 20.58, a price-book ratio of 2.16, a price-earnings-to-growth (PEG) ratio of 0.99, a EV-to-Ebitda ratio of 18.21 and a price-sales ratio of 2.74.
The price-to-GF Value ratio is 1.26, earning the stock a GF Value rank of 3.
Devon Energy Corp
THOMPSON SIEGEL & WALMSLEY LLC reduced their investment in NYSE:DVN by 515,988 shares. The trade had a 0.54% impact on the equity portfolio. During the quarter, the stock traded for an average price of $68.16.
On 02/12/2023, Devon Energy Corp traded for a price of $63.54 per share and a market cap of $41.54Bil. The stock has returned 31.58% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 5 out of 10.
In terms of valuation, Devon Energy Corp has a price-earnings ratio of 6.67, a price-book ratio of 3.82, a EV-to-Ebitda ratio of 4.51 and a price-sales ratio of 2.18.
The price-to-GF Value ratio is 1.54, earning the stock a GF Value rank of 1.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
